Volume 139(2) pgs. 155-353 February 2022

1. Ovarian Cancer Is Not So Silent.

2. Symptoms of Women With High-Risk Early-Stage Ovarian Cancer.

3. Identifying Cases of Severe Maternal Morbidity: Moving Beyond the Delivery Hospitalization.

4. Using Longitudinally Linked Data to Measure Severe Maternal Morbidity.

5. Pregnancy-Associated Deaths Due to Drugs, Suicide, and Homicide in the United States, 2010-2019.

6. Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination.

7. Effects of the Zishen Yutai Pill Compared With Placebo on Live Births Among Women in a Fresh Embryo Transfer Cycle: A Randomized Controlled Trial.

8. Survival Without Severe Neonatal Morbidity in Very Preterm Twins According to Planned Mode of Delivery.

9. Medically Assisted Reproduction Treatment Types and Birth Outcomes: A Between-Family and Within-Family Analysis.

10. Trends in Venous Thromboembolism and Associated Risk Factors During Delivery Hospitalizations From 2000 to 2018.

12. Variations in Low-Risk Cesarean Delivery Rates in the United States Using the Society for Maternal-Fetal Medicine Definition.

13. Experiences of New Mothers During the Coronavirus Disease 2019 (COVID-19) Pandemic.

14. Outpatient Cervical Ripening with Balloon Catheters: A Systematic Review and Meta-analysis.

15. Association of Medicaid Expansion Under the Affordable Care Act With Perinatal Care Access and Utilization Among Low-Income Women: A Systematic Review and Meta-analysis.

16. Surgical Removal of Midurethral Sling in Women Undergoing Surgery for Presumed Mesh-Related Complications: A Systematic Review.

17. Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review.

18. Pharmacologic Treatment for Perinatal Mental Health Disorders.

19. Insurance-Mediated Disparities in Gynecologic Oncology Care.

20. Antenatal Three-Dimensional Printing for Ex Utero Intrapartum Treatment Procedures.

21. What Obstetrician-Gynecologists Should Know About Substance Use Disorders in the Perinatal Period.

22. Evaluation of a Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol.

23. In Reply.

24. Postpartum Heparin Thromboprophylaxis: More Harm than Good.

25. In Reply.

26. Testosterone Therapy in Women: A Clinical Challenge.

27. In Reply.

28. Evaluation of a Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol: Correction.

29. Homicide During Pregnancy and the Postpartum Period in the United States, 2018-2019: Correction.

30. Prognostic Value of an Estimate-of-Risk Model in Critically Ill Obstetric Patients in Brazil: Correction.

31. ACOG Committee Opinion No. 809, Human Papillomavirus Vaccination: Correction.

32. ACOG Committee Opinion No. 823, Health Care for Transgender and Gender Diverse Individuals: Correction.

33. ACOG Publications: February 2022.

34. Patient-Centered Contraceptive Counseling: ACOG Committee Statement Number 1.